Elisabeth Schraml

2.5k citations
22 papers · 637 indexed · h-index 14

Elisabeth Schraml

22 papers receiving 627 citations

Peers

Elisabeth Schraml
Comparison fields: 5 of 87
  • Cancer Research 235
  • Aging 15
  • Molecular Biology 381
  • Hematology 60
  • Physiology 130
Replace Joonseok Cho with:
Joonseok Cho United States
Yan Xie China
Su‐Kang Shan China
Sudeshna Fisch United States
Gemma Olmos Spain
Lisa S. Ang Canada
Stéphanie Miard Canada
Satoshi Sugita Japan
Jesper Grud Skat Madsen Denmark
Fanny L. Casado Peru
Elisabeth Schraml relative to Joonseok Cho United States Joonseok Cho's profile →
Citations per field
00.5×1.5×2.4×
Joonseok Cho · 1×
Citations per year

Countries citing papers authored by Elisabeth Schraml

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Schraml's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Schraml with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Schraml more than expected).

Fields of papers citing papers by Elisabeth Schraml

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Schraml. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Schraml. The network helps show where Elisabeth Schraml may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Elisabeth Schraml, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elisabeth Schraml Line = papers co-authored together Elisabeth Schraml links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20196
2 201732
3 201267
4 201232
5 201113
6 20117
7 20119
8 201015
9 200810
10 200826
11 20087
12 20081
13
Anticancer activity of novel extracts from Cautleya gracilis (Smith) Dandy: apoptosis in human medullary thyroid carcinoma cells.
20089
14 200726
15 20078
16 200531
17 200426
18 200342
19 200316
20 200376

About Elisabeth Schraml

Elisabeth Schraml is a scholar working on Behavioral Neuroscience, Cancer Research and Genetics, having authored 22 papers that have together received 637 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Mesenchymal stem cell research (4 papers), Stress Responses and Cortisol (3 papers), Extracellular vesicles in disease (3 papers), Immune Cell Function and Interaction (3 papers), Adipose Tissue and Metabolism (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). The work is most often cited by research in Cancer Research (235 citations), Aging (15 citations) and Molecular Biology (381 citations). Elisabeth Schraml has collaborated with scholars based in Austria, Denmark and Netherlands. Frequent co-authors include Johannes Grillari, Regina Grillari‐Voglauer, Hannes Oberkofler, Franz Krempler, Wolfgang Patsch, Sylvia Weilner, Heinz Redl, Thomas Lion, Konrad Schauenstein and Robert Fuchs. Their work appears in journals such as Biochemical Journal, Experimental Cell Research and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026